https://www.selleckchem.com/products/sr4370.html
Introduction According to several guidelines, stereotactic body radiation therapy (SBRT) for early hepatocellular carcinoma (HCC) can be considered an alternative to other modalities, such as resection, radiofrequency ablation (RFA), and transarterial chemoembolization (TACE), or when these therapies have failed or are contraindicated. This article reviews the current status of SBRT for the treatment of HCC.Areas covered From the results of many retrospective reports, SBRT is a promising modality with an excellent local control of almost
Like
Comment
Share
